Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Opus Genetics Stock News

IRDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.7351

At close: Apr 17 EDT

$0.7895

0.057.40%

Pre-Market: 8:22 AM EDT

Opus Genetics (IRD) Forecast

News

Earnings Opus Genetics (IRD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Opus Genetics Stock News | NASDAQ:IRD | Benzinga

Get the latest news on Opus Genetics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Opus Genetics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, April 11, 2025

Craig-Hallum Initiates Coverage On Opus Genet...
Benzinga Newsdesk - 5 days ago

Tuesday, April 08, 2025

Opus Genetics Announces One-Month Clinical Da...
Benzinga Newsdesk - Apr 8, 2025, 8:16AM

Tuesday, April 01, 2025

Jones Trading Maintains Buy on Opus Genetics,...
Benzinga Newsdesk - Apr 1, 2025, 8:24AM
HC Wainwright & Co. Reiterates Buy on Opus Ge...
Benzinga Newsdesk - Apr 1, 2025, 7:27AM

Monday, March 31, 2025

Opus Genetics FY24 EPS ($2.15) Down From ($0...
Benzinga Newsdesk - Mar 31, 2025, 8:28AM

Friday, March 21, 2025

Opus Genetics Presents The LYNX-1 Phase 3 Stu...
Benzinga Newsdesk - Mar 21, 2025, 9:32AM
Opus Genetics Announces The Pricing Of An Und...
Benzinga Newsdesk - Mar 21, 2025, 9:13AM

Thursday, March 20, 2025

Ird Nvs pus Genetics Inc Filed Complaint For ...
Benzinga Newsdesk - Mar 20, 2025, 9:32AM

Tuesday, March 18, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Mar 18, 2025, 1:05PM

Wednesday, February 26, 2025

Opus Genetics Receives FDA Fast Track Designa...
Benzinga Newsdesk - Feb 26, 2025, 8:04AM

Wednesday, February 19, 2025

HC Wainwright & Co. Reiterates Buy on Opus Ge...
Benzinga Newsdesk - Feb 19, 2025, 7:12AM

Tuesday, February 18, 2025

Opus Genetics Announced That The First Pediat...
Benzinga Newsdesk - Feb 18, 2025, 7:36AM

Thursday, December 19, 2024

Opus Genetics shares are trading higher after...
Benzinga Newsdesk - Dec 19, 2024, 3:41PM
Opus Genetics Secures FDA Agreement Under Spe...
Benzinga Newsdesk - Dec 19, 2024, 8:08AM
Opus Genetics Receives FDA Agreement Under Sp...
Benzinga Newsdesk - Dec 19, 2024, 8:06AM

Thursday, December 12, 2024

HC Wainwright & Co. Reiterates Buy on Opus Ge...
Benzinga Newsdesk - Dec 12, 2024, 6:29AM

Tuesday, November 12, 2024

Opus Genetics Q3 EPS $(0.29) Down From $0.25 ...
Benzinga Newsdesk - Nov 12, 2024, 8:18AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved